Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6510117rdf:typepubmed:Citationlld:pubmed
pubmed-article:6510117pubmed:issue3lld:pubmed
pubmed-article:6510117pubmed:dateCreated1985-2-4lld:pubmed
pubmed-article:6510117pubmed:abstractTextCircadian systems are intermodulated by networks of specialized neural, hormonal and cellular functions, with time structures that are interdependent. In cardiovascular pathophysiology, circadian and ultradian rhythms of clinical interest have been demonstrated. Cardiac output, heart rate, arterial pressure and blood volume are the best known. Systolic and diastolic blood pressure and heart rate have circadian patterns in health and therefore arterial pressure cannot be evaluated by a single measurement during a 24-h span. With correct monitoring for at least 48-h it is possible to detect the mesor-hypertension and the possible amplitude-hypertension that precedes the mesor-hypertension. Prolonged elevation of blood pressure can cause irreparable harm to sensitive tissues. To quantify the damage, the concept of hyperbaric impact has been introduced. This is a measure of the excess load exerted upon the arterial walls. Studies of the beta-blocker penbutolol with correct automatic monitoring have shown the persistence of the physiological circadian variation in the cardiovascular parameters during penbutolol administration. The so-called elimination of the circadian rhythm in blood pressure, which would not really be desirable, was not seen in any of our patients, whose cardiovascular parameters were monitored continuously, day and night, while taking penbutolol. The amplitudes of the rhythms were always prominent. A phase shift, a delay of about 100 degrees, was demonstrated in the heart rate of one 63-year-old mesor-normotensive woman.lld:pubmed
pubmed-article:6510117pubmed:languageenglld:pubmed
pubmed-article:6510117pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6510117pubmed:citationSubsetIMlld:pubmed
pubmed-article:6510117pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6510117pubmed:statusMEDLINElld:pubmed
pubmed-article:6510117pubmed:issn0390-0037lld:pubmed
pubmed-article:6510117pubmed:authorpubmed-author:HalbergFFlld:pubmed
pubmed-article:6510117pubmed:authorpubmed-author:CarandenteFFlld:pubmed
pubmed-article:6510117pubmed:authorpubmed-author:AhlgrenAAlld:pubmed
pubmed-article:6510117pubmed:issnTypePrintlld:pubmed
pubmed-article:6510117pubmed:volume11lld:pubmed
pubmed-article:6510117pubmed:ownerNLMlld:pubmed
pubmed-article:6510117pubmed:authorsCompleteYlld:pubmed
pubmed-article:6510117pubmed:pagination189-203lld:pubmed
pubmed-article:6510117pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6510117pubmed:meshHeadingpubmed-meshheading:6510117-...lld:pubmed
pubmed-article:6510117pubmed:meshHeadingpubmed-meshheading:6510117-...lld:pubmed
pubmed-article:6510117pubmed:meshHeadingpubmed-meshheading:6510117-...lld:pubmed
pubmed-article:6510117pubmed:meshHeadingpubmed-meshheading:6510117-...lld:pubmed
pubmed-article:6510117pubmed:meshHeadingpubmed-meshheading:6510117-...lld:pubmed
pubmed-article:6510117pubmed:meshHeadingpubmed-meshheading:6510117-...lld:pubmed
pubmed-article:6510117pubmed:meshHeadingpubmed-meshheading:6510117-...lld:pubmed
pubmed-article:6510117pubmed:meshHeadingpubmed-meshheading:6510117-...lld:pubmed
pubmed-article:6510117pubmed:meshHeadingpubmed-meshheading:6510117-...lld:pubmed
pubmed-article:6510117pubmed:articleTitleMesor-hypertension: hints by chronobiologists.lld:pubmed
pubmed-article:6510117pubmed:publicationTypeJournal Articlelld:pubmed